Faecal and periurethral flora after oral administration of sulphonamide, nitrofurantoin and nalidixic acid.
D000284:Administration, Oral; D002675:Child, Preschool; D004352:Drug Resistance, Microbial; D004755:Enterobacteriaceae / Q000187:drug effects; D004926:Escherichia coli / Q000187:drug effects; D005243:Feces / Q000382:microbiology*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007223:Infant; D008297:Male; D009268:Nalidixic Acid / Q000008:administration & dosage* / Q000627:therapeutic use; D009582:Nitrofurantoin / Q000008:administration & dosage* / Q000627:therapeutic use; D012141:Respiratory Tract Infections / Q000188:drug therapy*; D012737:Sex Factors; D013444:Sulfisoxazole / Q000008:administration & dosage* / Q000627:therapeutic use; D013997:Time Factors; D014521:Urethra / Q000382:microbiology*; D014552:Urinary Tract Infections / Q000188:drug therapy*
D009268:Nalidixic Acid; D013444:Sulfisoxazole; D009582:Nitrofurantoin